Skip to main content
. 2023 May 5;42:115. doi: 10.1186/s13046-023-02683-4

Fig. 1.

Fig. 1

Study design showing the precision cohort as the group of patients who received treatment for metastatic colorectal cancer based on successful biopsy and drug screening performed in patient-derived tumor organoids